They discuss the life science academic infrastructure and provide additional details on the specific types of biotech and pharmaceutical companies working in the state.Dr. Russell Medford, co-chair of the BIO 2009 conference steering committee, Charles Craig, member of the conference executive committee, and Stephen Hill, member of the conference steering committee describe the major advantages of